Tranylcypromine Sulfate
Pronouncation: (tran-ill-SIP-row-meen SULL-fate)Class: MAO inhibitor
Trade Names:
Parnate
- Tablets 10 mg
Pharmacology
Feedback for Tranylcypromine Sulfate
Compare with other drugs. |
Tranylcypromine blocks activity of enzyme MAO, thereby increasing monoamine (eg, epinephrine, norepinephrine, serotonin) concentrations in CNS.
Pharmacokinetics
Absorption
Tranylcypromine appears to be well absorbed following oral administration of 30 mg/day. T max is 3 h; however, max inhibition of MAO occurs within 5 to 7 days. There is a rapid onset of activity.
Metabolism
Tranylcypromine is metabolized with the release of the active metabolite. In activation is primarily by acetylation.
Elimination
The drug is excreted in 24 h.
Onset
Onset of action is from 48 h to 3 wk.
Special Populations
Slow acetylatorsSlow acetylators may yield exaggerated effects after standard dosing.
Indications and Usage
Treatment of reactive depression.
Unlabeled Uses
Bulimia; treatment of panic disorders with associated agoraphobia.
Contraindications
Hypersensitivity to MAO inhibitors; pheochromocytoma; CHF; abnormal liver function; history of liver disease; severe renal function impairment; cerebrovascular defect; concurrent use of another MAO inhibitor, tricyclic or SSRI antidepressants, dextromethorphan, or CNS depressants (eg, alcohol), meperidine, sympathomimetic drugs (eg, amphetamines, dopamine, pseudoephedrine), or related drugs (eg, methyldopa, levodopa), buspirone, cheese or food with high tyramine content; cardiovascular disease; hypertension; history of headache; patients older than 60 yr (possibility of cerebral sclerosis).
Dosage and Administration
AdultsPO 10 mg 3 times daily initially; if no improvement after 2 wk, titrate up to 60 mg/day in 10 mg/day increments at intervals of 1 to 3 wk.
Storage/Stability
Store tablets at room temperature in a tightly closed container.
Drug Interactions
Amine-containing foodsMay cause severe hypertension or hemorrhagic strokes.
AnorexiantsMay cause exaggerated pharmacologic effects (eg, severe headaches, hypertension, hyperpyrexia) of anorexiants (eg, amphetamines, related compounds).
CNS depressantsMay enhance CNS effects.
DextromethorphanConcurrent use has been associated with severe reactions (eg, hyperpyrexia, hypotension, death).
Fluoxetine, fluvoxamine, nefazodone, paroxetine, sertraline, trazodone, venlafaxineAlthough data are limited, interactions comparable to those of tricyclic antidepressants and tranylcypromine may occur.
GuanethidineMAO inhibitors may antagonize antihypertensive effect. Insulin and sulfonylureas may enhance hypoglycemic action.
LevodopaMay cause hypertensive reactions.
MeperidineMay lead to severe reactions, including agitation, convulsions, diaphoresis, fever, respiratory depression, and vascular collapse.
SympathomimeticsMay cause severe headache, hypertensive crisis, and hyperpyrexia.
Tricyclic antidepressants, busipirone, carbamazepine, CNS stimulants, cyclobenzaprine, maprotiline, tyramineMay lead to potentially fatal reactions, including seizures and hypertensive crisis, mental status changes, hyperthermia.
Laboratory Test Interactions
None well documented.
Adverse Reactions
Cardiovascular
Orthostatic hypotension; edema; hypertensive crisis; palpitations; tachycardia.
CNS
Dizziness; headache; sleep disturbances; tremors; hyperreflexion; manic symptoms; muscle twitching; convulsions; vertigo; confusion; memory impairment; toxic delirium; hypomania; coma.
Dermatologic
Rash; sweating; photosensitivity.
EENT
Blurred vision; glaucoma; dry mouth.
GI
Constipation; nausea; diarrhea; anorexia; abdominal pain.
Genitourinary
Sexual dysfunction; urinary retention; incontinence.
Hematologic
Anemia; leukopenia; agranulocytosis; thrombocytopenia.
Hepatic
Fatal progressive necrotizing hepatocellular damage; elevated serum transaminases; hepatitis.
Metabolic
Weight gain; hypermetabolic syndrome (eg, fever, tachycardia, rapid breathing, rigidity, metabolism, acidosis, coma); hypernatremia.
Precautions
Pregnancy
Category undetermined.
Lactation
Excreted in breast milk.
Children
Not recommended for patients under 16 yr.
Elderly
Use with caution; older patients may suffer more morbidity than younger patients.
Diabetes
May alter glucose control.
Epilepsy
May lower seizure threshold.
Depression
May aggravate coexisting symptoms such as anxiety and agitation.
Hyperthyroidism
Use with caution because of increased sensitivity to pressor amines.
Suicidal patients
Strict supervision may be necessary in patients at risk.
Overdosage
Symptoms
Excitement, hypotension, dizziness, movement disorders, irritability, insomnia, weakness, severe headache, anxiety, restlessness, drowsiness, coma, convulsions, flushing, hypertension, sweating, tachypnea, acidosis, hyperpyrexia, tachycardia, cardiorespiratory arrest, incoherence, agitation, mental confusion, shock.
Patient Information
- Advise patient that antidepressants restore depressed people to normal moods.
- Inform patient and family that it may be 3 to 4 wk before a noticeable improvement in mood is noted.
- Instruct patient to take the medication at the same time every day.
- Advise patient not to take any other medications, including otc or prescription medications without checking with their health care provider first. This medication interacts with a large number of other medications.
- Teach patient to avoid sudden position changes to prevent orthostatic hypotension.
- Instruct patient and family on how to take BP. If the BP is markedly higher than normal, they should notify the health care provider.
- Warn patient that eating foods that contain tyramine or tryptophan while taking this medication can produce hypertensive crisis which is potentially fatal. These foods include, but are not limited to, protein foods that are aged or fermented such as cheeses, pickled herring, liver, hard sausage, pods of broad beans, beer, red wine, yeast extract, yogurt, ginseng, soy sauce, bananas, raisins, and avocados. Arrange for a consultation with a dietitian.
- Instruct patient to ingest caffeine and chocolate only in small amounts.
- Inform patient to avoid the use of alcohol and other recreational drugs.
- Advise patient to use caution while driving or performing other tasks requiring mental alertness until effect is determined.
- Instruct patient to stop taking the medication and notify the health care provider immediately if any of the following occurs: severe headache, chest pain, rapid heart beat, eye pain or photophobia, severe sweating, stiff neck, nausea, or vomiting.
| Link to this page | ![]() |
Printable Version | ![]() |
Email Page | ![]() |
Add to my drug list |
More Tranylcypromine Sulfate resources:
Parnate - Includes detailed dosage instructions.
Tranylcypromine Sulfate Images
Tranylcypromine Sulfate Drug Interactions














